PULMONX CORPORATION Interest Expense
PULMONX CORPORATION (LUNG) reported Interest Expense of $883.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-03.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-03
- PULMONX CORPORATION interest expense for the quarter ending 2024-03-31 was $883.00K, a 54.64% increase year-over-year.
- PULMONX CORPORATION interest expense for the quarter ending 2023-12-31 was $905.00K, a 152.09% increase year-over-year.
- PULMONX CORPORATION interest expense for the quarter ending 2023-09-30 was $893.00K, a 212.24% increase year-over-year.
- PULMONX CORPORATION interest expense for the quarter ending 2023-06-30 was $864.00K, a 287.44% increase year-over-year.
- PULMONX CORPORATION interest expense for fiscal 2023 was $3.23M, a 203.19% increase from fiscal 2022.
- PULMONX CORPORATION interest expense for fiscal 2022 was $1.07M, a 28.59% increase from fiscal 2021.
- PULMONX CORPORATION interest expense for fiscal 2021 was $829.00K, a 73.94% decline from fiscal 2020.
- PULMONX CORPORATION interest expense for fiscal 2020 was $3.18M, a 37.29% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $883.00K 10-Q · filed 2024-05-03 | $1.79M derived: sum of 2 quarters · filed 2024-05-03 | $2.68M derived: sum of 3 quarters · filed 2024-05-03 | $3.54M derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-12-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.80M derived: sum of 2 quarters · filed 2024-02-27 | $2.66M derived: sum of 3 quarters · filed 2024-02-27 | $3.23M 10-K · filed 2024-02-27 |
| 2023-09-30 | $893.00K 10-Q · filed 2023-11-03 | $1.76M derived: sum of 2 quarters · filed 2023-11-03 | $2.33M 10-Q · filed 2023-11-03 | $2.69M derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-06-30 | $864.00K 10-Q · filed 2023-08-04 | $1.44M 10-Q · filed 2023-08-04 | $1.79M derived: sum of 3 quarters · filed 2024-05-03 | $2.08M derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-03-31 | $571.00K 10-Q · filed 2024-05-03 | $930.00K derived: sum of 2 quarters · filed 2024-05-03 | $1.22M derived: sum of 3 quarters · filed 2024-05-03 | $1.44M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $645.00K derived: sum of 2 quarters · filed 2024-02-27 | $868.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.07M 10-K · filed 2024-02-27 |
| 2022-09-30 | $286.00K 10-Q · filed 2023-11-03 | $509.00K derived: sum of 2 quarters · filed 2023-11-03 | $707.00K 10-Q · filed 2023-11-03 | $906.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $223.00K 10-Q · filed 2023-08-04 | $421.00K 10-Q · filed 2023-08-04 | $620.00K derived: sum of 3 quarters · filed 2023-08-04 | $827.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $198.00K 10-Q · filed 2023-05-08 | $397.00K derived: sum of 2 quarters · filed 2023-05-08 | $604.00K derived: sum of 3 quarters · filed 2023-05-08 | $810.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $406.00K derived: sum of 2 quarters · filed 2023-03-01 | $612.00K derived: sum of 3 quarters · filed 2023-03-01 | $829.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $207.00K 10-Q · filed 2022-11-08 | $413.00K derived: sum of 2 quarters · filed 2022-11-08 | $630.00K 10-Q · filed 2022-11-08 | $897.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $206.00K 10-Q · filed 2022-08-08 | $423.00K 10-Q · filed 2022-08-08 | $690.00K derived: sum of 3 quarters · filed 2022-08-08 | $1.79M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $217.00K 10-Q · filed 2022-05-09 | $484.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.59M derived: sum of 3 quarters · filed 2022-05-09 | $2.50M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.37M derived: sum of 2 quarters · filed 2022-03-01 | $2.28M derived: sum of 3 quarters · filed 2022-03-01 | $3.18M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.10M 10-Q · filed 2021-11-09 | $2.02M derived: sum of 2 quarters · filed 2021-11-09 | $2.91M 10-Q · filed 2021-11-09 | $3.36M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $912.00K 10-Q · filed 2021-08-10 | $1.81M 10-Q · filed 2021-08-10 | $2.26M derived: sum of 3 quarters · filed 2021-08-10 | $2.72M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $899.00K 10-Q · filed 2021-05-12 | $1.35M derived: sum of 2 quarters · filed 2021-05-12 | $1.81M derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $450.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $910.00K derived: sum of 2 quarters · filed 2021-03-15 | $2.32M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $460.00K 10-Q · filed 2020-11-13 | $1.87M 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | $2.52M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |